
Eisai has become the latest pharma firm to partner with the US-based Broad Institute to pool expertise and come up …

Bayer HealthCare and a prestigious US academic institution have signed a five-year deal to find new oncology treatments. The German …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

